✊ “We are in the midst of a revolution,” MIT’s Jonathan Gruber says.
“Insurance companies are going to face some very difficult decisions about drugs.”
GLP-1s represent the biggest problem with the US healthcare system
Related posts
-
Dovish BOE Pushback Could Undermine Pound: 3-Minutes MLIV
Bloomberg TelevisionThu, April 30, 2026 10:42amURL:Embed:Anna Edwards, Guy Johnson, Tom Mackenzie and Adam Linton break down... -
Manus Becomes Cautionary Tale As China Blocks Meta Deal
Bloomberg TelevisionThu, April 30, 2026 10:42amURL:Embed:The AI startup Manus, once a high-profile success story, is turning... -
1 Billion Same-Day Orders: Amazon’s Delivery Strategy: Earnings Call
Yahoo FinanceThu, April 30, 2026 10:42amURL:Embed:#amazon #earnings #yahoofinance Amazon is getting faster—and expanding in ways that...